DEF 14A: Scorpius Holdings Seeks Stockholder Approval for Reverse Stock Split and Share Issuance to Comply with NYSE American Listing Rules

Sentiment:

Proxy Statement


Scorpius Holdings is asking stockholders to approve a reverse stock split and a share issuance to maintain compliance with NYSE American listing rules and facilitate future financing.

Capital raiseThe company issued 9% senior secured convertible notes in the aggregate principal amount of $13,388,889 and warrants to purchase up to 13,388,889 shares of common stock for $12,050,000.The notes are convertible at $0.50 per share, and the warrants have an exercise price of $0.50 per share, subject to adjustments.The company received net proceeds of approximately $3.3 million from the offering, after repurchasing pre-funded warrants and redeeming a promissory note.

Summary

  • Scorpius Holdings is holding a special meeting of stockholders on January 16, 2025, to vote on three proposals.
  • The first proposal is to approve an amendment to the company's charter to effect a reverse stock split of its common stock at a ratio between 1-for-5 and 1-for-35, with the specific ratio to be determined by the Board of Directors.
  • The second proposal is to approve the issuance of more than 20% of the company's common stock as of December 5, 2024, pursuant to a securities purchase agreement, including upon conversion of senior secured convertible notes and exercise of warrants.
  • The third proposal is to approve the adjournment of the special meeting, if necessary, to solicit additional proxies if there are insufficient votes for the first two proposals.
  • The Board of Directors recommends voting FOR all three proposals.
  • As of December 13, 2024, there were 4,868,268 shares of common stock outstanding.
  • The company received a notice from NYSE Regulation on June 14, 2024, regarding the low selling price of its common stock and a potential delisting.
  • On July 17, 2024, the company effected a 1-for-200 reverse stock split.
  • The NYSE American withdrew its delisting determination on July 29, 2024, and trading resumed on August 2, 2024.
  • On December 5, 2024, the company issued 9% senior secured convertible notes in the aggregate principal amount of $13,388,889 and warrants to purchase up to 13,388,889 shares of common stock for $12,050,000.
  • The notes are convertible at $0.50 per share, and the warrants have an exercise price of $0.50 per share, subject to adjustments.
  • The company received net proceeds of approximately $3.3 million from the offering, after repurchasing pre-funded warrants and redeeming a promissory note.
  • The number of shares issuable upon conversion of the notes and exercise of the warrants is subject to an exchange cap of 865,820 shares, unless stockholder approval is obtained to issue shares in excess of the cap.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While the company is taking proactive steps to address its low stock price and maintain its listing, there are inherent risks associated with the proposed actions, such as potential dilution and market uncertainty. The company's past delisting notice and reliance on financing also contribute to a neutral-to-slightly-positive outlook.

Positives

  • Approval of the reverse stock split could help the company maintain its listing on the NYSE American.
  • The reverse stock split could broaden investor appeal and improve stock liquidity.
  • Approval of the share issuance proposal would allow the company to preserve cash by issuing shares upon conversion of notes and exercise of warrants.
  • The company has taken steps to address previous delisting concerns by implementing a reverse stock split in July 2024.

Negatives

  • The reverse stock split may not result in a sustained increase in the stock price.
  • The reverse stock split could decrease the liquidity of the common stock.
  • The reverse stock split may result in some stockholders owning odd lots, which can be more difficult to sell.
  • The reverse stock split may lead to a decrease in the overall market capitalization of the company.
  • Failure to approve the share issuance proposal could require the company to repay the notes in cash, impacting working capital.
  • Existing stockholders will experience dilution if the share issuance proposal is approved.

Risks

  • The market price of the common stock may not remain at a level sufficient to meet NYSE American requirements.
  • Delisting from the NYSE American could negatively impact the liquidity and trading volume of the common stock.
  • The reverse stock split may be viewed negatively by the market.
  • The company may incur additional costs and expenses related to holding additional stockholder meetings if the share issuance proposal is not approved.
  • The company's ability to fund operations could be adversely impacted if the share issuance proposal is not approved.

Future Outlook

The company intends to seek a listing on another national securities exchange if it is not successful in maintaining its listing on the NYSE American. The company may be required to hold additional stockholder meetings to obtain approval for the share issuance proposal. The company may need additional capital funding until it generates sufficient revenue from operations.

Management Comments

  • The Board of Directors believes that the failure of stockholders to approve the Reverse Stock Split Proposal could prevent the market price of our Common Stock from remaining at a level that will be sufficient to meet any requirements and policies of the NYSE American and could inhibit our ability to conduct capital raising activities, among other things.
  • The Board of Directors believes that if at the Special Meeting the number of votes represented by shares of our Common Stock present or represented and voting in favor is insufficient to approve the Reverse Stock Split Proposal or the Share Issuance Proposal, it is in the best interests of the stockholders to enable the Board to continue to seek to obtain a sufficient number of additional votes to approve the Reverse Stock Split Proposal or the Share Issuance Proposal.

Industry Context

Reverse stock splits are often used by companies to regain compliance with stock exchange listing requirements. Share issuance is a common method for companies to raise capital, but it can lead to dilution for existing shareholders. The document indicates that the company is facing challenges related to its stock price and is taking steps to address these challenges.

Comparison to Industry Standards

  • Many companies facing delisting from major exchanges due to low share prices implement reverse stock splits, such as what happened with DryShips Inc. before it was eventually delisted.
  • The terms of the convertible notes and warrants, including the conversion and exercise prices, are typical for small-cap companies seeking financing.
  • The 20% share issuance threshold requiring stockholder approval is a standard NYSE American listing rule.
  • The company's previous reverse split of 1-for-200 is a relatively high ratio, indicating the severity of the stock price decline.

Stakeholder Impact

  • Shareholders will be impacted by the potential reverse stock split and share issuance, which could affect the value and liquidity of their holdings.
  • Employees may be affected by the company's ability to maintain its listing and secure financing, which could impact job security and compensation.
  • The company's customers and suppliers may be affected by the company's financial stability and ability to continue operations.

Next Steps

  • Stockholders will vote on the proposals at the special meeting on January 16, 2025.
  • The Board of Directors will determine whether to implement the reverse stock split and at what ratio.
  • The company will file a certificate of amendment to the charter if the reverse stock split is approved and implemented.
  • The company may hold additional stockholder meetings to obtain approval for the share issuance proposal if it is not initially approved.
  • The company will monitor its stock price and compliance with NYSE American listing requirements.

Key Dates

DateDescription
June 14, 2024Received delisting notice from NYSE Regulation.
July 17, 2024Effected a 1-for-200 reverse stock split.
July 29, 2024NYSE American withdrew its delisting determination.
August 2, 2024Common stock resumed trading on the NYSE American.
December 5, 2024Entered into a Securities Purchase Agreement and issued convertible notes and warrants.
December 6, 2024Issued convertible notes and warrants in a private placement offering.
December 13, 2024Record date for the special meeting of stockholders.
December 19, 2024Began mailing the proxy statement.
January 2, 2025First business day of each fiscal quarter beginning.
January 15, 2025Deadline for submitting proxy votes by internet or telephone (11:59 p.m. Eastern Time).
January 16, 2025Special meeting of stockholders to be held at 10:00 a.m. Eastern Time.
February 17, 2025Deadline for submitting stockholder proposals for inclusion in next year's proxy materials.
March 17, 2025Earliest date for submitting stockholder proposals for the 2025 Annual Meeting.
March 31, 2025First deadline to obtain stockholder approval for the issuance of Conversion Shares and Warrant Shares in excess of the Exchange Cap.
April 16, 2025Latest date for submitting stockholder proposals for the 2025 Annual Meeting.
May 16, 2025Deadline to comply with the universal proxy rules.
July 1, 2025Second deadline to obtain stockholder approval for the issuance of Conversion Shares and Warrant Shares in excess of the Exchange Cap.

Keywords

reverse stock split, share issuance, proxy statement, NYSE American, convertible notes, warrants, stockholder approval, delisting, common stock, Scorpius Holdings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.